BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Argus Health
Chubb
McKesson
Federal Trade Commission
Express Scripts
Cipla
Cantor Fitzgerald
Dow
Merck

Generated: January 17, 2018

DrugPatentWatch Database Preview

EFAVIRENZ Drug Profile

« Back to Dashboard

When do Efavirenz patents expire, and when can generic versions of Efavirenz launch?

Efavirenz is a drug marketed by Mylan Pharms Inc and is included in one NDA.

The generic ingredient in EFAVIRENZ is efavirenz. There are twenty-five drug master file entries for this compound. Three suppliers are listed for this compound. There are twenty-eight tentative approvals for this compound. Additional details are available on the efavirenz profile page.

US Patents and Regulatory Information for EFAVIRENZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc EFAVIRENZ efavirenz TABLET;ORAL 091471-001 Feb 17, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Medtronic
Cipla
Cerilliant
UBS
Chinese Patent Office
Dow
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot